Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;76(3):145-154.
doi: 10.1007/s00251-024-01337-9. Epub 2024 Mar 7.

Lack of Syndecan-1 promotes the pathogenesis of experimental rheumatoid arthritis

Affiliations

Lack of Syndecan-1 promotes the pathogenesis of experimental rheumatoid arthritis

Rosalyn Jurjus et al. Immunogenetics. 2024 Jun.

Abstract

Syndecan-1 (Sdc-1), a transmembrane heparan sulfate protein, is implicated in several pathophysiological processes including rheumatoid arthritis (RA). The exact role of Syndican-1 in this autoimmune disease is still undetermined. This study explores the involvement level of Sdc-1 in the development of RA in a collagen II-induced arthritis mice model. RA was induced in two mice strains (wild-type BALB/c group and Sdc-1 knockout) by collagen II. Mice underwent regular clinical observations and scoring. After sacrifice, leg biopsies were taken from mice for histological examination, using a variety of stains. In addition, proteins were extracted, and molecular assessment of TNF-α was performed using the western blot technique. In the Sdc-1 knockout group, clinical scoring results showed a significantly more severe experimental RA; histology showed a significant increase in bone erosion, cartilage destruction, inflammation, and less granulated mast cells than the wild-type. In addition, molecular assessment of TNF-α showed more increase in expression in the Sdc-1 knockout models compared to the wild-type. Data suggest that lack of Sdc-1 enhances the inflammatory characteristics in RA. However, more molecular studies and investigations are needed to determine its exact role and possible mechanisms involved.

Keywords: Autoimmune diseases; Chronic inflammation; Rheumatoid arthritis; Syndecan-1.

PubMed Disclaimer

References

    1. Agere SA, Kim EY, Akhtar N, Ahmed A (2018) Syndecans in chronic inflammatory and autoimmune diseases: pathological insights and therapeutic opportunities. J cell physiol. https://doi.org/10.1002/jcp.26388 - DOI - PubMed - PMC
    1. Day RM, Mitchell TJ, Knight SC, Forbes A (2003) Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine 21:224–233. https://doi.org/10.1016/s1043-4666(03)00091-7 - DOI - PubMed
    1. Deyab G, Reine TM, Vuong TT et al (2021) Antirheumatic treatment is associated with reduced serum Syndecan-1 in rheumatoid arthritis. PLoS ONE 16:e0253247. https://doi.org/10.1371/journal.pone.0253247 - DOI - PubMed - PMC
    1. Fischer AH, Jacobson KA, Rose J, Zeller R (2018) CSH Protoc 2008:pdb-rot4986. https://doi.org/10.1101/pdb.prot4986 - DOI
    1. Furman D, Campisi J, Verdin E et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822–1832. https://doi.org/10.1038/s41591-019-0675-0 - DOI - PubMed - PMC

Publication types

MeSH terms

LinkOut - more resources